<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Habib T</submitter><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>717-31</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2080907</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>179(4)</volume><pubmed_abstract>Deregulated expression of the Myc family of transcription factors (c-, N-, and L-myc) contributes to the development of many cancers by a mechanism believed to involve the stimulation of cell proliferation and inhibition of differentiation. However, using B cell-specific c-/N-myc double-knockout mice and E(mu)-myc transgenic mice bred onto genetic backgrounds (recombinase-activating gene 2-/- and Btk-/- Tec-/-) whereby B cell development is arrested, we show that Myc is necessary to stimulate both proliferation and differentiation in primary B cells. Moreover, Myc expression results in sustained increases in intracellular Ca2+ ([Ca2+]i), which is required for Myc to stimulate B cell proliferation and differentiation. The increase in [Ca2+]i correlates with constitutive nuclear factor of activated T cells (NFAT) nuclear translocation, reduced Ca2+ efflux, and decreased expression of the plasma membrane Ca2+-adenosine triphosphatase (PMCA) efflux pump. Our findings demonstrate a revised model whereby Myc promotes both proliferation and differentiation, in part by a remarkable mechanism whereby Myc amplifies Ca2+ signals, thereby enabling the concurrent expression of Myc- and Ca2+-regulated target genes.</pubmed_abstract><journal>The Journal of cell biology</journal><pubmed_title>Myc stimulates B lymphocyte differentiation and amplifies calcium signaling.</pubmed_title><pmcid>PMC2080907</pmcid><funding_grant_id>R01CA20525</funding_grant_id><funding_grant_id>R01AI0535468</funding_grant_id><funding_grant_id>R01 AI053568-05</funding_grant_id><funding_grant_id>R01 AI053568-03</funding_grant_id><funding_grant_id>R01 AI053568</funding_grant_id><funding_grant_id>R01 CA020525</funding_grant_id><funding_grant_id>R01 AI053568-04</funding_grant_id><funding_grant_id>R01 AI053568-01A1</funding_grant_id><funding_grant_id>R01 AI053568-02</funding_grant_id><pubmed_authors>Park H</pubmed_authors><pubmed_authors>de Alboran IM</pubmed_authors><pubmed_authors>Eisenman RN</pubmed_authors><pubmed_authors>Rawlings DJ</pubmed_authors><pubmed_authors>Nicks A</pubmed_authors><pubmed_authors>Andrews S</pubmed_authors><pubmed_authors>Habib T</pubmed_authors><pubmed_authors>Tsang M</pubmed_authors><pubmed_authors>Wilson L</pubmed_authors><pubmed_authors>Iritani BM</pubmed_authors><pubmed_authors>Knoepfler PS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myc stimulates B lymphocyte differentiation and amplifies calcium signaling.</name><description>Deregulated expression of the Myc family of transcription factors (c-, N-, and L-myc) contributes to the development of many cancers by a mechanism believed to involve the stimulation of cell proliferation and inhibition of differentiation. However, using B cell-specific c-/N-myc double-knockout mice and E(mu)-myc transgenic mice bred onto genetic backgrounds (recombinase-activating gene 2-/- and Btk-/- Tec-/-) whereby B cell development is arrested, we show that Myc is necessary to stimulate both proliferation and differentiation in primary B cells. Moreover, Myc expression results in sustained increases in intracellular Ca2+ ([Ca2+]i), which is required for Myc to stimulate B cell proliferation and differentiation. The increase in [Ca2+]i correlates with constitutive nuclear factor of activated T cells (NFAT) nuclear translocation, reduced Ca2+ efflux, and decreased expression of the plasma membrane Ca2+-adenosine triphosphatase (PMCA) efflux pump. Our findings demonstrate a revised model whereby Myc promotes both proliferation and differentiation, in part by a remarkable mechanism whereby Myc amplifies Ca2+ signals, thereby enabling the concurrent expression of Myc- and Ca2+-regulated target genes.</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Nov</publication><modification>2025-04-19T07:37:38.803Z</modification><creation>2019-03-26T23:02:29Z</creation></dates><accession>S-EPMC2080907</accession><cross_references><pubmed>17998397</pubmed><doi>10.1083/jcb.200704173</doi></cross_references></HashMap>